Apollomics APLM
NASDAQ APLM
$22.05 +0.95 (+4.56%)
As of: Oct 19, 2026 · 12:55 PM EDT

Apollomics (APLM) Assets (2021 - 2025)

Updated

Apollomics (APLM) recorded Assets of $6.71 million in Q4 2025, down 48.7% from $13.1 million a year earlier.

Analysis

Apollomics (APLM) Assets (2021 - 2025) Analysis & Trends

Starting with Q4 2021, Apollomics' Assets history includes 8 quarters.

  • Annual Assets has declined for four straight years, with a four-year compound annual growth rate of -51.7% (FY2021 to FY2025).
  • Across earlier years, Assets came in at $13.1 million in FY2024 (-11.2%), $14.76 million in FY2023 (-0.1%), $14.78 million in FY2022 (-88.0%) and $123.44 million in FY2021.
  • The Q4 2025 figure is the lowest quarterly Assets in data going back to Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 201.06 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 135.12 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 115.83 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 49.36 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 201.13 Bn
10 Apollomics 44.32 Mn 3.22 Mn - 6.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 6.71 Mn
Jun 30, 2025 11.12 Mn
Dec 31, 2024 13.10 Mn
Jun 30, 2024 34.57 Mn
Dec 31, 2023 55.39 Mn
Jun 30, 2023 71.38 Mn
Dec 31, 2022 76.48 Mn
Dec 31, 2021 123.44 Mn
API Access

Apollomics Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=APLM&period=max&api_key=YOUR_API_KEY